136 related articles for article (PubMed ID: 30139235)
1. Expression of Micro-RNA 128 and Let-7b in Pediatric Acute Lymphoblastic Leukemia Cases.
Shafik RE; Abd El Wahab N; Senoun SA; Ebeid E; El Taweel MA
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2263-2267. PubMed ID: 30139235
[TBL] [Abstract][Full Text] [Related]
2. Expression of microRNA-181a and microRNA-196b in Egyptian Pediatric acute Lymphoblastic Leukemia.
Shafik RE; Abd El Wahab N; Mokhtar MM; El Taweel MA; Ebeid E
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3429-3434. PubMed ID: 33247705
[TBL] [Abstract][Full Text] [Related]
3. Expression of certain leukemia/lymphoma related microRNAs and its correlation with prognosis in childhood acute lymphoblastic leukemia.
Nemes K; Csóka M; Nagy N; Márk Á; Váradi Z; Dankó T; Kovács G; Kopper L; Sebestyén A
Pathol Oncol Res; 2015 Jul; 21(3):597-604. PubMed ID: 25388103
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia.
Ghodousi ES; Rahgozar S
J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744
[TBL] [Abstract][Full Text] [Related]
5. [Expression Analysis and Epigenetics of MicroRNA let-7b in Acute Lymphoblastic Leukemia].
Xu WQ; Huang YM; Xiao HF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Dec; 23(6):1535-41. PubMed ID: 26708866
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA as a diagnostic biomarker in childhood acute lymphoblastic leukemia; systematic review, meta-analysis and recommendations.
Rashed WM; Hammad AM; Saad AM; Shohdy KS
Crit Rev Oncol Hematol; 2019 Apr; 136():70-78. PubMed ID: 30878131
[TBL] [Abstract][Full Text] [Related]
8. High miR-24 expression is associated with risk of relapse and poor survival in acute leukemia.
Organista-Nava J; Gómez-Gómez Y; Illades-Aguiar B; Del Carmen Alarcón-Romero L; Saavedra-Herrera MV; Rivera-Ramírez AB; Garzón-Barrientos VH; Leyva-Vázquez MA
Oncol Rep; 2015 Apr; 33(4):1639-49. PubMed ID: 25672522
[TBL] [Abstract][Full Text] [Related]
9. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
10. [Association of miRNAs expression profiles with prognosis and relapse in childhood acute lymphoblastic leukemia].
Xu L; Liang YN; Luo XQ; Liu XD; Guo HX
Zhonghua Xue Ye Xue Za Zhi; 2011 Mar; 32(3):178-81. PubMed ID: 21535956
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
[TBL] [Abstract][Full Text] [Related]
12. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia.
Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N
Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-181a and its target Smad 7 as potential biomarkers for tracking child acute lymphoblastic leukemia.
Nabhan M; Louka ML; Khairy E; Tash F; Ali-Labib R; El-Habashy S
Gene; 2017 Sep; 628():253-258. PubMed ID: 28732737
[TBL] [Abstract][Full Text] [Related]
14. Micro-RNA-16 expression in paraffin-embedded specimen correlates with overall survival of T-lymphoblastic lymphoma/leukemia.
Xi Y; Li J; Zan L; Wang J; Wang G; Ning Y
Hum Pathol; 2013 Jun; 44(6):1011-6. PubMed ID: 23260326
[TBL] [Abstract][Full Text] [Related]
15. [Preliminary analysis of aberrant expression of plasma miR-223 in pediatric acute lymphoblastic leukemia with a direct RT-PCR assay].
Lu XJ; Jiang Q; Huang PL; Li G; Zhang WJ; Zhao XX; Zheng HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):68-72. PubMed ID: 23484694
[TBL] [Abstract][Full Text] [Related]
16. Circulating miR-146a expression as a non-invasive predictive biomarker for acute lymphoblastic leukemia.
Shahid S; Shahid W; Shaheen J; Akhtar MW; Sadaf S
Sci Rep; 2021 Nov; 11(1):22783. PubMed ID: 34815474
[TBL] [Abstract][Full Text] [Related]
17. Lack of Association between the MiR146a Polymorphism and Susceptibility to Thai Childhood Acute Lymphoblastic Leukemia.
Chansing K; Pakakasama S; Hongeng S; Thongmee A; Pongstaporn W
Asian Pac J Cancer Prev; 2016; 17(5):2435-8. PubMed ID: 27268610
[TBL] [Abstract][Full Text] [Related]
18. Impact of miR-155 and miR-126 as novel biomarkers on the assessment of disease progression and prognosis in adult T-cell leukemia.
Ishihara K; Sasaki D; Tsuruda K; Inokuchi N; Nagai K; Hasegawa H; Yanagihara K; Kamihira S
Cancer Epidemiol; 2012 Dec; 36(6):560-5. PubMed ID: 22884882
[TBL] [Abstract][Full Text] [Related]
19. miRNA-155 and miRNA-181a as prognostic biomarkers for pediatric acute lymphoblastic leukemia.
El-Khazragy N; Noshi MA; Abdel-Malak C; Zahran RF; Swellam M
J Cell Biochem; 2019 Apr; 120(4):6315-6321. PubMed ID: 30362157
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]